| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 2.9e-05 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |